US Stock MarketDetailed Quotes

TMDX TransMedics

Watchlist

92.340
+3.090+3.46%

Trading Apr 26 10:21 ET

3.03BMarket Cap-119922P/E (TTM)

TransMedics Stock Forum

Moomoo AI

Mar 11 22:53

TransMedics Group's trend of growing ROCE and increasing capital employed suggests profitable reinvestment opportunities, potentially leading to a multi-bagger performance. The stock's solid return to shareholders over the last three years indicates investor recognition of these changes.

The Return Trends At TransMedics Group (NASDAQ:TMDX) Look Promising

Rockyturki

Mar 11 11:19

$Advanced Micro Devices(AMD.US)$ was obvious to buy at $100 and many waited
$Celsius Holdings(CELH.US)$ at $48 (this year) was the easiest money and people waited.
$Palantir(PLTR.US)$ at $14 was extremely undervalued and many waited
$Meta Platforms(META.US)$ was obvious to buy at $200 and everyone waited
$CrowdStrike(CRWD.US)$ was a clear buy at $150 and people waited
$TransMedics(TMDX.US)$ at $38 with a market cap of $1 Billion was a steal and nobody wanted to buy it.
Focus on the essentials: align...

Kevin Travers

Feb 28 00:02

ColumnsBiotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Moomoo AI

Jan 25 22:59

Insider selling over the past year, particularly in recent months, may indicate insiders believe shares are overpriced. Despite some insider buying, the long-term outlook lacks positivity. Insider ownership shows alignment with shareholders, but past sales warrant caution.

TransMedics Group Insiders Sell US$2.1m Of Stock, Possibly Signalling Caution

Moomoo AI

Dec 14, 2023 20:08

TransMedics Group's significant top-line growth is undermined by its negative EBIT, liabilities outstripping cash and near-term receivables by $75m, and increased cash burn over the past year, constituting substantial risk.

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Moomoo AI

Nov 7, 2023 21:59

Oppenheimer analysts hail TransMedics' recent quarter as 'blockbuster', emphasizing its long-term strategy to overcome short term challenges. The game-changing potential of the Organ Care System technology to reshape organ preservation and transport is also highlighted.

TransMedics' Stock Pops After Organ-transplant Company's 'Blockbuster' Third-quarter Results

Pinchie McPincher

Nov 7, 2023 18:03

wheres everyone
and why did this run up all on its own

Moomoo AI

Oct 10, 2023 19:54

Positive interpretation of recent purchases at TransMedics Group amidst potential concerns over last year's sales. Insiders' stakes display alignment between management and smaller shareholders.

TransMedics Group Insiders Sold US$1.9m Of Shares Suggesting Hesitancy

Cramer ETF

Jan 19, 2023 15:03

Cramer’s lightning round: TransMedics is a total winner $TransMedics(TMDX.US)$

Ming-ChiKuo Tracking

Jan 3, 2023 17:53

Small and mid cap picks

Just want to get a conversation going about small to mid cap companies ($500 million to $5 billion market cap range) you believe will experience growth in the next few years.
Stocks in this price range can have more risk, but they typically have larger growth potential than the large caps.
What are your picks and why?
$TransMedics(TMDX.US)$$Matterport(MTTR.US)$$Apple(AAPL.US)$$SoFi Technologies(SOFI.US)$$S&P 500 Index(.SPX.US)$$Invesco QQQ Trust(QQQ.US)$

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall